Characterizing the tumor and immune landscape of patients with melanoma treated with combined checkpoint blockade and MAPK-targeted therapy

被引：0
|
作者：
Zisman, Liron Pola
Gushterova, Irena
LaSalle, Thomas
Blaum, Emily
Sharova, Tatyana
Liu, Mofei
Giobbie-Hurder, Anita
Sade-Feldman, Moshe
Yizhak, Keren
Hacohen, Nir
Sullivan, Ryan J.
机构：
[1] Rambam Hlth Care, Div Oncol, Haifa, Israel
[2] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[3] Massachusetts Gen Hosp, Surg Oncol, Canc Ctr, Boston, MA USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Div Biostat, Dept Data Sci, Boston, MA USA
[5] Dana Farber Canc Inst, Boston, MA USA
[6] Massachusetts Inst Technol MIT & Harvard, Broad Inst, Cambridge, MA USA
[7] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
[8] Harvard Med Sch HMS, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[9] Massachusetts Gen Canc Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21503
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy
    Li, Man
    Yang, Yuting
    Xu, Chaoqun
    Wei, Jiaojie
    Liu, Yingke
    Cun, Xingli
    Yu, Qianwen
    Tang, Xian
    Yin, Sheng
    Zhang, Zhirong
    He, Qin
    AAPS JOURNAL, 2019, 21 (02):
  • [32] Hypogonadism in melanoma patients under immune checkpoint blockade
    de Vos, L.
    Fietz, S.
    Fetter, T.
    Hillebrand, P.
    Allam, P.
    Landsberg, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 105 - 105
  • [33] Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint Blockade
    Galant-Swafford, Jessica
    Troesch, Adrien
    Tran, Lisa
    Weaver, Ashley
    Doherty, Taylor A.
    Patel, Sandip Pravin
    ONCOLOGY, 2020, 98 (02) : 123 - 130
  • [34] Bilateral murine tumor models for characterizing the response to immune checkpoint blockade
    Zemek, Rachael M.
    Fear, Vanessa S.
    Forbes, Cath
    de Jong, Emma
    Casey, Thomas H.
    Boon, Louis
    Lassmann, Timo
    Bosco, Anthony
    Millward, Michael J.
    Nowak, Anna K.
    Lake, Richard A.
    Lesterhuis, W. Joost
    NATURE PROTOCOLS, 2020, 15 (05) : 1628 - 1648
  • [35] Bilateral murine tumor models for characterizing the response to immune checkpoint blockade
    Rachael M. Zemek
    Vanessa S. Fear
    Cath Forbes
    Emma de Jong
    Thomas H. Casey
    Louis Boon
    Timo Lassmann
    Anthony Bosco
    Michael J. Millward
    Anna K. Nowak
    Richard A. Lake
    W. Joost Lesterhuis
    Nature Protocols, 2020, 15 : 1628 - 1648
  • [36] Combining targeted therapy and immune checkpoint blockade to improve responses
    Wargo, Jennifer A.
    CANCER RESEARCH, 2015, 75
  • [37] Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis
    Straker, Richard J., III
    Thaler, Alexandra S.
    Shannon, Adrienne B.
    Miura, John T.
    Chu, Emily Y.
    Karakousis, Giorgos C.
    Ming, Michael E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (01) : 169 - 172
  • [38] Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
    Cooper, Zachary A.
    Reuben, Alexandre
    Spencer, Christine N.
    Prieto, Peter A.
    Austin-Breneman, Jacob L.
    Jiang, Hong
    Haymaker, Cara
    Gopalakrishnan, Vancheswaran
    Tetzlaff, Michael T.
    Frederick, Dennie T.
    Sullivan, Ryan J.
    Amaria, Rodabe N.
    Patel, Sapna P.
    Hwu, Patrick
    Woodman, Scott E.
    Glitza, Isabella C.
    Diab, Adi
    Vence, Luis M.
    Rodriguez-Canales, Jaime
    Parra, Edwin R.
    Wistuba, Ignacio I.
    Coussens, Lisa M.
    Sharpe, Arlene H.
    Flaherty, Keith T.
    Gershenwald, Jeffrey E.
    Chin, Lynda
    Davies, Michael A.
    Clise-Dwyer, Karen
    Allison, James P.
    Sharma, Padmanee
    Wargo, Jennifer A.
    ONCOIMMUNOLOGY, 2016, 5 (03):
  • [39] Immune-mediated eosinophilic Fasciitis under Immune Checkpoint Blockade and the Intolerability of targeted Therapy in Patient with metastatic Melanoma
    Meisterfeld, S.
    Garzarolli, M.
    Beissert, S.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 54 - 54
  • [40] Plasma proteomic analyses and treatment predictive biomarker candidates in melanoma patients receiving immune checkpoint blockade or targeted therapy.
    Eriksson, Hanna
    Babacic, Haris
    Lehtio, Janne
    Pernemalm, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345